Other OTC - Delayed Quote • USD
Oncology Pharma Inc. (ONPH)
At close: April 25 at 12:05 PM EDT
Breakdown
TTM
Total Revenue
94.0000
Cost of Revenue
29.0000
Gross Profit
65.0000
Operating Expense
650.0000
Operating Income
-585.0000
Other Income Expense
78.0000
Net Income Common Stockholders
-507.0000
Diluted NI Available to Com Stockholders
-507.0000
Basic Average Shares
0.0020
Diluted Average Shares
0.0020
Total Operating Income as Reported
-585.0000
Total Expenses
679.0000
Net Income from Continuing & Discontinued Operation
-507.0000
Normalized Income
-553.8000
EBIT
-585.0000
EBITDA
-585.0000
Reconciled Cost of Revenue
29.0000
Reconciled Depreciation
12.0000
Net Income from Continuing Operation Net Minority Interest
-507.0000
Total Unusual Items Excluding Goodwill
78.0000
Total Unusual Items
78.0000
Normalized EBITDA
-663.0000
Tax Rate for Calcs
0.0004
Tax Effect of Unusual Items
31.2000
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RGBP Regen BioPharma, Inc.
0.7400
0.00%
DRMAW Dermata Therapeutics, Inc.
0.0095
+3.26%
RGBPP Regen BioPharma, Inc.
1.9500
-39.06%
INFIQ Infinity Pharmaceuticals, Inc.
0.0000
0.00%
ORPHA.CO Orphazyme A/S
1,100.00
+2.34%
GUTS Fractyl Health, Inc.
6.72
+6.84%
EVLO Evelo Biosciences, Inc.
0.0457
+3.39%
DBVT DBV Technologies S.A.
0.6894
+3.67%
PMVP PMV Pharmaceuticals, Inc.
1.7100
+1.18%
BOLT Bolt Biotherapeutics, Inc.
1.1600
-2.52%